Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

NCT04766398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: KHK7791
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.